M
Michael Hennig
Researcher at Hoffmann-La Roche
Publications - 106
Citations - 5957
Michael Hennig is an academic researcher from Hoffmann-La Roche. The author has contributed to research in topics: Binding site & Carnitine. The author has an hindex of 39, co-authored 102 publications receiving 5451 citations. Previous affiliations of Michael Hennig include University of Cologne & University of Göttingen.
Papers
More filters
Journal ArticleDOI
The isolation and use of a benzodiazepine iminochloride for the efficient construction of flumazenil
TL;DR: The benzodiazepine iminochloride 2 has been isolated, characterized and its reaction with a glycinate enolate synthon investigated resulting in an efficient synthesis of the imidazobenzodiazepines flumazenil.
Journal ArticleDOI
Carnitine palmitoyltransferase 2: analysis of membrane association and complex structure with a substrate analog.
TL;DR: The crystal structure of rat CPT‐2 in complex with the substrate analogue palmitoyl‐aminocarnitine at 1.8 Å resolution is determined and a strong effect of this compound on rCPT‐2 activity and stability is revealed.
Journal ArticleDOI
X-ray structure of glutathione S-transferase from Schistosoma japonicum in a new crystal form reveals flexibility of the substrate-binding site
TL;DR: The structure of orthorhombic SjGST reveals unique features of the ligand-binding site and dimer interface when compared with previously reported structures, which might prove to be valuable for the development of novel drugs.
Journal ArticleDOI
Synthesis of (1S,3aS)-8- (2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro [4.5]decan-4-one, a Potent and Selective Orphanin FQ (OFQ) Receptor Agonist with Anxiolytic-Like Properties.
Juergen Wichmann,Geo Adam,Stephan Roever,Michael Hennig,Michelangelo Scalone,Cesura Andrea,Frank M. Dautzenberg,Francois Jenck +7 more
Patent
[6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)amine hydrochloride polymorph
TL;DR: In this article, a novel polymorph of [6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)amine hydrochloride is presented.